Abstract:Background: YKL-40, which is also known as Chitiniase 3-like 1, has been found to be up-regulated in many autoimmune diseases including asthma, systemic sclerosis and systemic lupus, etc. However, the relationship between serum levels of YKL-40 and one another common autoinmmue thyroid disease - Graves' disease (GD) has not yet been investigated.Objective: The current study was performed to investigate the correlation of serum YKL-40 levels with disease severity of initially diagnosed GD.Methods: A total of 142 newly diagnosed active GD and 137 healthy individuals were enrolled in the study. Methimazole was given to 55 GD patients and then 2-month study of follow-up was performed. A commercial ELISA kit was applied for the detection of YKL-40 in serum. Degree of goiter was assessed according to Pérez's Grade. Receiver operating characteristic (ROC) curve analysis was carried out to detect the diagnostic value of serum YKL-40 with regard to goiter degree. The velocity of the peak systolic blood-flow and the thyroid tissue blood flow (TBF) were examined using Color Flow Doppler ultrasonography (CFDU).Results: The patients with GD exhibited dramatically higher YKL-40 in serum compared to those of healthy controls (606.1 ± 149.8 pg/mL vs. 397.4 ± 95.1 pg/mL, P < 0.001). Positive associations of YKL-40 with free T3 (FT3) and T4 (FT4), as well as the negative correlation of YKL-40 with TSH in serum, were observed. Additionally, the YKL-40 in serum was dramatically reduced after methimazole intervention, and the correlation of the decline with the reduced FT3 and FT4 was also found (all P < 0.001). Serum YKL-40 levels were positively correlated with goiter degree. ROC curve analysis demonstrated that serum YKL-40 concentration may act as a decent marker for goiter degree. The positive correlations of YKL-40 in serum with the average superior thyroid artery velocity (STV) and thyroid tissue blood flow (TBF) were also observed.Conclusion: Our findings implicated that YKL-40 may be closely connected to the pathogenesis of GD. Increased YKL-40 levels are linked with disease severity of initially diagnosed GD.

Characterization and Clinical Relevance of Circulating CD4+CD28− T Cells in Graves’ Disease

The Role of Circulating CD4+ CD28- T Cell in the Development of Graves' Disease

Impairment of Regulatory Capacity of Cd4(+)Cd25(+) Regulatory T Cells Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves' Disease

Association Of Graves' Disease And Prevalence Of Circulating Ifn-Gamma-Producing Cd28(-) T Cells

Phenotypic Characteristics of the CD4+CD28- T Cell Subsets in Peripheral Blood of Patients with Graves Disease and Its Clinical Significance

Constitutive Changes in Circulating Follicular Helper T Cells and Their Subsets in Patients with Graves’ Disease

A High Frequency Of Circulating Th22 And Th17 Cells In Patients With New Onset Graves' Disease

Significance of T Cell Subsets and Expression of Costimulatory Molecule in Periph Eral Blood of Patients with Graves' Disease and Its Implication on Clinical Outcome

Correction Between Cytokine Expressions in Circulating CD4~+ CD28~-T Cells and Graves'ophthalmopathy

CD11c+ B Cells Participate in the Pathogenesis of Graves’ Disease by Secreting Thyroid Autoantibodies and Cytokines

Effects of Thyrostatic Treatment on T,B Lymphocytes and Expression of Costimulatory Molecules on Pripheral Blood Lymphocytes of Patients with Graves' Disease

The relationship between CD4~+ CD25~+ regulatory T cell and Graves' disease

Elevated Follicular Helper T Cells and Expression of IL-21 in Thyroid Tissues Are Involved in the Pathogenesis of Graves' Disease.

Expansion of Inflammatory Monocytes in Periphery and Infiltrated into Thyroid Tissue in Graves' Disease.

Plasmacytoid dendritic cells,interferon-α and CD4~+ CD25~+ regulatory T cells in immunopathogenic mechanism of Graves disease

Absolute reduction in peripheral regulatory T cells in patients with Graves’ disease and post-treatment recovery

Decrease in Proportion of Cd19(+)Cd24(Hi)Cd27(+) B Cells and Impairment of Their Suppressive Function in Graves' Disease

Expression of Costimulatory Molecule in Thyroid Tissue of Graves' Disease

Elevated Expression and Activation of GPR15 in Immune Cells in Graves' Disease

Different Levels of Circulating Th22 Cell and Its Related Molecules in Graves' Disease and Hashimoto's Thyroiditis.

Increased YKL-40 Levels Are Linked with Disease Severity of Initially Diagnosed Graves’ Disease